Company Announcements - Dameng Data's board member and senior vice president is under investigation by the Hubei Provincial Supervisory Committee, but the company's operations remain normal [1] - Jishi Media reported a net loss of 232 million yuan in the first half of 2025, despite a revenue increase of 8.7% to 999.7 million yuan [2] - Wantai Biological's nine-valent HPV vaccine has received its first batch release certificate, marking its market entry and potential revenue growth [2] - Feilu Co., Ltd. is undergoing a change in control, leading to a suspension of its stock trading starting August 22 [2] Financial Performance - Sany Heavy Industry reported a 46% increase in net profit to 5.216 billion yuan in the first half of 2025, with a revenue of 44.534 billion yuan, up 14.96% [3] - EVE Energy's net profit decreased by 24.9% to 1.605 billion yuan, despite a revenue increase of 30.06% to 28.169 billion yuan [5] - GoerTek achieved a net profit increase of 15.65% to 1.42 billion yuan, with a revenue of 37.55 billion yuan, down 7.02% [6] Approvals and Projects - Changchun High-tech's subsidiary received acceptance for a clinical trial application for GenSci143, a dual-specificity antibody drug targeting B7-H3 and PSMA [7] - Zejing Pharmaceutical received approval for clinical trials of ZG005 and ZGGS18 in combination with a specific cancer drug [7] Financing and Capital Increase - Zhenghe Industrial plans to raise no more than 818 million yuan through a private placement for various projects and working capital [8] Shareholding Changes - Zhongyin Securities announced that Jiangxi Copper plans to reduce its stake by up to 3%, equating to 83.34 million shares [9] - Mengke Pharmaceutical's shareholders plan to transfer 22.946 million shares, representing 3.5% of the total share capital [15] Investments and Strategic Partnerships - Diou Home plans to establish a wholly-owned subsidiary with an investment of 500 million yuan to expand into the generative AI field [11] - Gree Green signed a strategic cooperation agreement with Weilan Lithium to develop ultra-high energy density battery materials and solid-state battery innovations [12]

Group 1: Company Performance - Sinopec reported a revenue of 1.4 trillion yuan and a net profit of 23.75 billion yuan for the first half of 2025, with a cash dividend of 0.088 yuan per share, representing a payout ratio of 49.7% [1] - GoerTek achieved a net profit of 1.42 billion yuan, marking a year-on-year increase of 15.65%, despite a revenue decline of 7.02% to 37.55 billion yuan [2] - Gree Electric announced a cash dividend of 20 yuan per 10 shares, totaling 11.17 billion yuan, based on a share base of 5.585 billion shares [3] - Jishi Media reported a revenue of 999.7 million yuan, with a net loss of 232 million yuan for the first half of 2025 [4] - Changchun High-tech's subsidiary received approval for a clinical trial of a dual-specific antibody drug, GenSci143, targeting B7-H3 and PSMA [5] - Greenme announced a strategic partnership with Weilan Lithium to develop high-energy battery materials and solid-state battery technologies [6] Group 2: Share Buybacks and Reductions - Sinopec plans to repurchase shares worth between 5 billion and 10 billion yuan through the Shanghai Stock Exchange [26] - Jiangxi Copper intends to reduce its stake in Zhongyin Securities by up to 3%, equating to 83.34 million shares [7] - Hengbang Mining plans to reduce its stake in the Hong Kong-listed company, WanGuo Gold, by up to 3.69% of its total share capital [10] Group 3: New Product Developments - Renhe Pharmaceutical's subsidiary is developing a brain-machine interaction smart glasses product, which is currently in the testing phase and has not yet generated sales revenue [11] - TianTan Bio received a commitment from its controlling shareholders to resolve new competition issues arising from a recent acquisition [12] - XianDao Intelligent has successfully developed a mass production solution for solid-state batteries and received repeat orders for related products [13] - Zejing Pharmaceutical received approval for clinical trials of ZG005 and ZGGS18 in combination with a cancer treatment drug [14] - Wantai Bio received a production approval for its nine-valent HPV vaccine, marking a new revenue stream [15]

智通财经APP讯，三未信安(688489.SH)发布2025年半年度报告，报告期内，公司实现营业收入1.95亿 元，同比增长15.19%。归属于上市公司股东净亏损2938.58万元。归属于上市公司股东的扣除非经常性 损益净亏损3335.52万元。基本每股亏损0.2615元。 ...

三未信安公告，2025年上半年营业收入为1.95亿元，同比增长15.19%；归属于上市公司股东的净亏损 2938.58万元，上年同期为盈利1370.93万元。 ...

Group 1 - The company Sanwei Xinan (SH 688489) announced on August 21 that its 19th meeting of the second board of directors was held, discussing the proposal to reappoint the auditing firm for the fiscal year 2025 [2] - For the fiscal year 2024, the company's revenue composition is as follows: 67.73% from product and solution vendors, 31.6% from end customers, and 0.67% from other businesses [2]

Market Performance - The Shanghai Composite Index rose by 0.13% to 3771.1 points, while the Shenzhen Component Index fell by 0.06% to 11919.76 points, and the ChiNext Index decreased by 0.47% to 2595.47 points. The STAR Market 50 Index increased by 0.09% to 1149.15 points. The total trading volume in the Shanghai and Shenzhen markets reached 24240.57 billion yuan [1]. Sector Movements - Digital currency concept stocks showed strong performance, with companies like Yuyin Co., Ltd. hitting the daily limit. The photovoltaic sector was also active, with companies such as Beibo Co., Ltd. reaching the daily limit [1]. Notable Stocks - Several stocks related to the photovoltaic sector, such as Shimao Energy and Zhangzhou Development, achieved daily limit gains due to factors like waste incineration power generation and state-owned enterprise reforms [6]. - Digital currency-related stocks like Tianrongxin and Sanwei Xinan also saw daily limit gains, driven by developments in digital currency and AI security [6]. Industry Insights - According to a report from CITIC Securities, central bank digital currencies (CBDCs) have advantages over traditional electronic payments, private cryptocurrencies, and stablecoins, including sovereign credit backing, strong scalability, good privacy, low costs, and fast transactions. The digital yuan possesses these advantages and has promising applications in programmability, smart contracts, cross-border payments, and promoting the internationalization of the yuan [7].

Group 1 - The company, Sanwei Xinan (688489.SH), reported a revenue of 195 million yuan for the first half of 2025, representing a year-on-year growth of 15.19% [1] - The net profit attributable to shareholders of the listed company was -29.39 million yuan [1] - The basic earnings per share were -0.2615 yuan [1]

证券代码：688489 证券简称：三未信安 公告编号：2025-065 三未信安科技股份有限公司 关于选举职工代表董事的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重 大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 附件：范希骏先生简历 范希骏先生，1974 年 12 月生，中国国籍，无境外永久居留权，毕业于山东 大学，硕士研究生学历，应用数学专业。1997 年 7 月至 1998 年 5 月，任台湾垦 懋科技有限公司济南办事处程序员，1998 年 5 月至 2001 年 5 月，历任济南市电 信局程序员、项目经理；2001 年 5 月至 2007 年 5 月，任济南得安计算机技术有 限公司设备部部门经理；2007 年 5 月至 2008 年 8 月，任北京知安信科技有限公 司技术负责人；2008 年 8 月至 2020 年 10 月，任北京三未信安科技发展有限公 司副总经理、首席技术专家；2018 年 11 月至今，任山东多次方半导体有限公司 法定代表人、执行董事；2020 年 10 月至今，任三未信安科技股份有限公司董事、 首席技术专家。 截至本公告披露日，范 ...

证券代码：688489 证券简称：三未信安 公告编号：2025-064 三未信安科技股份有限公司 关于取消监事会、调整董事会人数及修订《公司章程》的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重 大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 三未信安科技股份有限公司（以下简称"公司"）于 2025 年 8 月 21 日召开 第二届董事会第十九次会议，审议通过了《关于取消监事会、调整董事会人数 及修订<公司章程>的议案》，现将有关情况公告如下： 一、 取消监事会、调整董事会人数情况 根据《公司法》《上市公司章程指引》（以下简称"《章程指引》"）等有关法 律法规和规范性文件的规定，并结合公司实际情况，公司将不再设置监事会与 监事，由董事会审计委员会行使《公司法》规定的监事会职权，同时《三未信 安科技股份有限公司监事会议事规则》相应废止，公司各项规章制度中涉及监 事会、监事的规定不再适用。 在公司股东大会审议通过取消监事会事项前，公司第二届监事会仍将严格 按照《公司法》《证券法》《上市公司治理准则》等法律法规和规范性文件的要 求，勤勉尽责履行监督职能，维护公司和全体股 ...

三未信安科技股份有限公司 独立董事工作制度 二〇二五年八月 第三条 独立董事对公司及全体股东负有诚信与勤勉义务。独立董事应当按 照法律、行政法规、中国证券监督管理委员会（以下简称中国证监会）规定、证 券交易所业务规则和《公司章程》的规定，认真履行职责，维护公司整体利益和 全体股东利益，尤其要关注中小股东的合法权益不受损害。独立董事应当独立履 行职责，不受公司主要股东、实际控制人或者其他与公司存在利害关系的单位或 个人的影响。 三未信安科技股份有限公司 独立董事工作制度 第一章 总则 第一条 为进一步完善三未信安科技股份有限公司（以下简称"公司"）治理 结构，促进公司独立董事规范、尽责履职，充分发挥独立董事在公司治理中的作 用，根据《中华人民共和国公司法》（以下简称"《公司法》"）、《上海证券交易所 科创板股票上市规则》《上市公司独立董事管理办法》（以下简称"《管理办法》"） 等法律、法规、规范性文件和《三未信安科技发展股份有限公司章程》（以下简 称"《公司章程》"）的相关规定，制定本制度。 第二条 独立董事是指不在上市公司担任除董事外的其他职务，并与其所受 聘的上市公司及其主要股东、实际控制人不存在直接或者间 ...